Chronic Dual Inhibition of Angiotensin-Converting Enzyme and Neutral Endopeptidase During the Development of Left Ventricular Dysfunction in Dogs

Publisher Website
Google Scholar
Abstract
Angiotensin-converting enzyme (ACE) inhibition as well as neutral endopeptidase (NEP) inhibition was demonstrated to influence hemodynamics in various cardiac disease states. However, specific effects of chronic combined ACE and NEP inhibition on left ventricular (LV) and myocyte geometry and function remain unclear. In this study, a dual-acting metalloprotease inhibitor (DMPI), which possesses both ACE and NEP inhibitory activity, was used in a rapid-pacing model of LV dysfunction. LV and myocyte geometry and function were examined in control dogs (n = 6), in dogs with pacing-induced LV dysfunction (216 ± 2 beats/min, 28 days, n = 7), and in dogs with DMPI treatment during rapid pacing (10 mg/kg p.o., b.i.d., n = 6). With chronic rapid pacing, LV end-diastolic volume increased (84 ± 4 vs. 49 ± 3 ml), and LV ejection fraction decreased (38 ± 3% vs. 68 ± 3%) compared with control (p 2